Month: May 2025

Cycurion’s W. Eric Singleton to Speak at the Armed Forces Communication and Electronics Association’s TechNet Cyber 2025 on Active Cyber Defense Innovation

Written by Customer Service on May 7, 2025. Posted in Public Companies.

MCLEAN, Va., May 07, 2025 (GLOBE NEWSWIRE) — Cycurion (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity solutions and AI, announces that W. Eric Singleton, Vice President of Operations, will be a featured speaker at the Armed Forces Communications and Electronics Association’s (AFCEA) TechNet Cyber 2025, one of the premier events for cyber leaders in the Department of Defense, intelligence community, and defense industry. Mr. Singleton’s presentation is titled, “ARx: Active Cyber Defense & Deception Platform, a transformative approach to cyber defense that turns attacker reconnaissance into a costly and intelligence-yielding operation.” With over two decades of experience in national security and technology leadership, Mr. Singleton will highlight how ARx is reshaping cyber defense for modern...

Florida Healthcare Leader Embraces Daxor Blood Volume Analysis Technology

Written by Customer Service on May 7, 2025. Posted in Public Companies.

Daxor’s ezBVA Lab Service Marks New Standard in Precision Fluid Management Oak Ridge, TN, May 07, 2025 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the opening of a new BVA program at a premier Florida healthcare center in the Tampa Bay region. This expansion integrates Daxor’s innovative blood volume analysis (BVA) testing across the facility’s inpatient and outpatient care programs, revolutionizing fluid management precision and enhancing treatment outcomes for a spectrum of conditions. The facility will utilize Daxor’s state-of-the-art Tennessee-based CLIA-certified ezBVA Lab that delivers comprehensive blood volume analysis results within 24 hours of sample receipt. “This exciting hallmark marks another significant milestone...

Krystal Biotech to Present at BofA Securities 2025 Health Care Conference

Written by Customer Service on May 7, 2025. Posted in Public Companies.

PITTSBURGH, May 07, 2025 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the BofA Securities 2025 Health Care Conference on May 14, 2025, in Las Vegas. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 11:20 am PT and host investor meetings throughout the day. A webcast of the presentation will be available here beginning at 11:20 am PT on Wednesday, May 14, 2025 and will be posted on the Investors section of the Company’s website. About Krystal Biotech, Inc. Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK®,...

22nd Century Group Further Reduces Debt by $1.0 Million Following Financing Transaction

Written by Customer Service on May 7, 2025. Posted in Public Companies.

Year to Date Total Debt Reduction of approximately $3.8 Million MOCKSVILLE, N.C., May 07, 2025 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced that has repaid an additional $1 million in debt to its senior lender. The Company’s total debt principal outstanding now stands at approximately $3.9 million. “Our debt reduction progress has been outstanding and total debt principal is now less than $4 million, as compared with approximately $20 million of total debt obligations when I joined the Company in December 2023,” said Larry Firestone, CEO of 22nd Century Group. We are on our way to becoming debt free, which will allow us to focus our resources...

Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update

Written by Customer Service on May 7, 2025. Posted in Earnings Releases And Operating Results.

Company remains on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025 Initiated APOLLO, a confirmatory clinical trial of bitopertin in adults and adolescents with EPP Plan to initiate Phase 2 study of DISC-3405 in polycythemia vera (PV) in H1 2025 Expect data readouts for DISC-0974 program in H2 2025, including initial results of Phase 2 anemia of myelofibrosis (MF) study and multiple dose data from Phase 1b anemia of non-dialysis dependent chronic kidney disease (NDD-CKD) study Strong financial position supported by $259 million public offering in January 2025; ended Q1 with $695 million in cash, cash equivalents, and marketable securities, which is expected to fund operations into 2028 Company to host virtual MF Anemia KOL Day on Friday, May 9 at 1:00 PM ET / 10:00 AM PTWATERTOWN, Mass., May 07,...

GCM Grosvenor Reports First Quarter 2025 Earnings Results, with Quarter-To-Date Fundraising Increasing 77% Year-Over-Year, Quarter-to-Date GAAP Net Income of $0.5 million, and Fee-Related Earnings and Adjusted Net Income Increasing 22% and 30%, Respectively, Year-Over-Year

Written by Customer Service on May 7, 2025. Posted in Earnings Releases And Operating Results.

CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) — GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, today reported its results for the first quarter 2025. GCM Grosvenor issued a detailed presentation of its results to the Public Shareholders section of GCM Grosvenor’s website at https://www.gcmgrosvenor.com/shareholder-events. GCM Grosvenor’s Board of Directors approved a $0.11 per share dividend payable on June 16, 2025 to shareholders on record June 6, 2025. Conference CallA conference call to discuss GCM Grosvenor’s financial results will be held today, Wednesday, May 7, 2025, at 10:00 a.m. ET. The call will be accessible via public webcast from the Public Shareholders section of GCM Grosvenor’s website at https://www.gcmgrosvenor.com/shareholder-events, and a replay of the live broadcast will...

Intermex Reports First-Quarter Results

Written by Customer Service on May 7, 2025. Posted in Earnings Releases And Operating Results.

Company reports solid volume growth, continued execution of omnichannel strategy Company to Host Conference Call Today at 9 a.m. ET MIAMI, May 07, 2025 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI) (“Intermex” or the “Company”), one of the nation’s leading global omnichannel money transfer services to Latin America and the Caribbean, today reported financial and operating results for the first quarter of 2025. Financial performance highlights for the first quarter of 2025:Revenues of $144.3 million Net income of $7.8 million Diluted EPS of $0.25 Adjusted Diluted EPS of $0.35 Adjusted EBITDA of $21.6 millionBob Lisy, Chairman, President, and CEO of Intermex, stated “Intermex’s first quarter results reflect the strength and discipline of the Intermex business model, despite an economic and political...

Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides Business Update

Written by Customer Service on May 7, 2025. Posted in Earnings Releases And Operating Results.

– End-of-Phase 2 meeting with FDA requested for Alzheimer’s disease – – Phase 2 results in dementia with Lewy bodies accepted for oral presentation at AAIC – – Two posters at ARVO describe zervimesine’s role supporting retinal cell health – PURCHASE, N.Y., May 07, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, today reported financial results for the first quarter ended March 31, 2025, and provided a business update. “During our first quarter of 2025 and in recent weeks, we continued to advance our Alzheimer’s disease and dementia with Lewy bodies (DLB) programs,” stated Lisa Ricciardi, Cognition’s president and CEO. “A request was made with the U.S. Food...

MasterCraft Boat Holdings, Inc. Reports Fiscal 2025 Third Quarter Results

Written by Customer Service on May 7, 2025. Posted in Earnings Releases And Operating Results.

VONORE, Tenn., May 07, 2025 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2025 third quarter ended March 30, 2025. The overview, commentary, and results provided herein relate to our continuing operations, which exclude our former Aviara segment. Overview:Net sales for the third quarter were $76.0 million, down $8.0 million, or 9.5%, from the comparable prior-year period Planned decrease in production contributed to approximately 30% lower dealer inventory levels compared to the prior-year Income from continuing operations was $3.8 million, or $0.23 per diluted share Adjusted Net Income, a non-GAAP measure, was $5.0 million, or $0.30 per diluted share Adjusted EBITDA, a non-GAAP measure, was $7.5 million, down $4.2 million from the comparable prior-year period Cash...

Amerigo Announces Q1-2025 Results & Quarterly Dividend

Written by Customer Service on May 7, 2025. Posted in Earnings Releases And Operating Results.

Q1-2025 Net Income of $3.3 million Robust EBITDA1 of $15.2 million and Free Cash Flow to Equity1 of $4.8 million 15th Quarterly Dividend of Cdn$.03 Declared $4.6 million Returned through Dividends and Share Buybacks in Q1-2025 VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is pleased to announce a strong financial performance for the three months ended March 31, 2025 (“Q1-2025”). Dollar amounts in this news release are in U.S. dollars unless indicated otherwise. Amerigo’s Q1-2025 financial results included net income of $3.3 million, earnings per share (“EPS”) of $0.02, EBITDA1 of $15.2 million, operating cash flow from operations before changes in non-cash working capital1 of $11.6 million and free cash flow to equity1 of $4.8 million....

Month: May 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals